[Ip-health] EU Slams Big Pharma for Blocking Generics, Seeks Public Comment in Prep of Antitrust Charges...

[Jay Purcell]

--
--
[ Picked text/plain from multipart/alternative ]
NYT article
http://www.nytimes.com/2008/11/29/business/worldbusiness/29drugs.html?pagewanted=print

EU Report "accuses big pharma of adding billions in costs" by obstructing
entry of generics (and also of some collusion with generic manufacturers to
delay entry).
Report includes seized documents from Pfizer, Sanofi, GSK,

http://ec.europa.eu/comm/competition/sectors/pharmaceuticals/inquiry/index.html
(fact sheets 1<http://ec.europa.eu/comm/competition/sectors/pharmaceuticals/inquiry/1_Prices_time_to_generic_entry_and_consumer_savings.pdf>
,
2<http://ec.europa.eu/comm/competition/sectors/pharmaceuticals/inquiry/2_Originator_Generic_competition.pdf>
,
3<http://ec.europa.eu/comm/competition/sectors/pharmaceuticals/inquiry/3_Originator_Originator_competition.pdf>
,
4<http://ec.europa.eu/comm/competition/sectors/pharmaceuticals/inquiry/4_Regulator_framework.pdf>
,
and FAQ<http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/08/746&format=HTML&aged=0&language=EN&guiLanguage=en>
 )
Report Attached.



They're looking for public input on the report by 31 Jan, in possible
preparation for antitrust charges...
Seems like a solid source to continue slamming Hatch-Waxman...

"The Commission invites interested stakeholders to submit their comments
about the preliminary findings of the sector inquiry presented in the
Preliminary Report by 31 January 2009. Comments should be sent to:
comp-sector-pharma@ec.europa.eu.

--
____________________________________________________________________
j. purcell // purcell@berkeley.edu // uc berkeley law school  //
us#607.26.26.26.7
--
X-Attachment-Id: f_fo6iug0v0

[ EU 2008 Prelim Report - Pharma Compet.pdf of type application/pdf deleted ]